SAREPTA THERDRNSAREPTA THERDRNSAREPTA THERDRN

SAREPTA THERDRN

No trades
See on Supercharts

SAREPTA THERDRN forum


SRPT FDA approved resuming Elevidys treatment for ambulatory patients, unfavorable FDA boss ousted. Depending on earnings and future guidance this may see a decent rebound.


SRPT "Sarepta Therapeutics Announces Voluntary Pause of ELEVIDYS Shipments in the U.S." 7/22/25






SRPT this is going to be an epic short squeeze. Buckle up